Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0O7DU
|
|||
Former ID |
DIB010501
|
|||
Drug Name |
CT-1746
|
|||
Indication | Colorectal cancer [ICD-11: 2B91.Z] | Terminated | [1] | |
Company |
Celltech Therapeutics Ltd
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H28ClN3O4
|
|||
Canonical SMILES |
CC(C)(C)C(C(=O)N)NC(=O)C(CCCC1=CC=C(C=C1)Cl)CC(=O)NO
|
|||
InChI |
1S/C19H28ClN3O4/c1-19(2,3)16(17(21)25)22-18(26)13(11-15(24)23-27)6-4-5-12-7-9-14(20)10-8-12/h7-10,13,16,27H,4-6,11H2,1-3H3,(H2,21,25)(H,22,26)(H,23,24)/t13-,16-/m1/s1
|
|||
InChIKey |
CZCIELLKWLGEFJ-CZUORRHYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006498) | |||
REF 2 | Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor. Clin Exp Metastasis. 1997 Mar;15(2):184-95. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.